Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

TAKAHASHI Yoshiko; TAKESUE Yoshio; NAKAJIMA Kazuhiko; ICHIKI Kaoru; TSUCHIDA Toshie; TATSUMI Sumiyo; ISHIHARA Mika; IKEUCHI Hiroki; UCHINO Motoi

Art

J-GLOBAL ID：201102229480550010 Reference number：11A1085015

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

リネゾリド療法を受けた患者における血小板減少症の発現に関与するリスクファクター

Publisher site Copy service
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1085015&from=J-GLOBAL&jstjournalNo=L2852A") }}

Author (9)： , , , , , , , ,
Material：
Volume： 17 Issue： 3 Page： 382-387 Publication year： Jun. 2011
JST Material Number： L2852A ISSN： 1341-321X Document type： Article
Article type：原著論文 Country of issue： United Kingdom (GBR) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1085015&from=J-GLOBAL&jstjournalNo=L2852A") }}

Hematologic diseases , Clinical application of antibacterial drugs , Poisoning in general

Reference (21)：

STEVENS, DL. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2002, 34, 1481-1490
PERRY, CM. Linezolid : a review of its use in the management of serious gram-positive infections. Drugs. 2001, 61, 525-551
MOELLERING, RC. Linezolid : the first oxazolidinone antimicrobial. Ann Intern Med. 2003, 138, 135-142
BERNSTEIN, WB. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother. 2003, 37, 517-520
WHITEHOUSE, T. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill. J Antimicrob Chemother. 2005, 55, 333-340

ｍore...

, , , , ,

Return to Previous Page